- Home
- Publications
- Publication Search
- Publication Details
Title
Locally Advanced Lung Cancer
Authors
Keywords
-
Journal
CANCER JOURNAL
Volume 19, Issue 3, Pages 247-262
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-05-24
DOI
10.1097/ppo.0b013e318292e51a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells
- (2014) S. Matsumura et al. JOURNAL OF IMMUNOLOGY
- Pathways of Antigen Processing
- (2013) Janice S. Blum et al. Annual Review of Immunology
- Alarmins, inflammasomes and immunity
- (2013) DavidM Ojcius et al. Biomedical Journal
- Incidence of Primary and Second Cancers in Renal Transplant Recipients: A Multicenter Cohort Study
- (2012) G. Tessari et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Combination immunotherapy approaches
- (2012) C. G. Drake ANNALS OF ONCOLOGY
- Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies
- (2012) M J McCoy et al. BRITISH JOURNAL OF CANCER
- Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer
- (2012) Raquibul Hannan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MAGE-A antigens as targets in tumour therapy
- (2012) David W. Meek et al. CANCER LETTERS
- Adjuvant immunotherapy for non-small cell lung cancer
- (2012) Zachary C.G. Tucker et al. CANCER TREATMENT REVIEWS
- The Effects of TLR Activation on T-Cell Development and Differentiation
- (2012) Bo Jin et al. Clinical & Developmental Immunology
- Optimizing Cancer Treatments to Induce an Acute Immune Response: Radiation Abscopal Effects, PAMPs, and DAMPs
- (2012) C. M. Ludgate CLINICAL CANCER RESEARCH
- Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
- (2012) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- Vaccines in non-small cell lung cancer: Rationale, combination strategies and update on clinical trials
- (2012) Tommaso De Pas et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Induction of Abscopal Anti-Tumor Immunity and Immunogenic Tumor Cell Death by Ionizing Irradiation - Implications for Cancer Therapies
- (2012) B. Frey et al. CURRENT MEDICINAL CHEMISTRY
- Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients: Update on Epidemiology, Risk Factors, and Management
- (2012) Gianpaolo Tessari et al. DERMATOLOGIC SURGERY
- Role of inflammatory dendritic cells in innate and adaptive immunity
- (2012) Cindy Hespel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immune alterations and emerging immunotherapeutic approaches in lung cancer
- (2012) Constantin A Dasanu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
- (2012) Thomas J. Lynch et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy
- (2012) Huagang Zhang et al. PLoS One
- Cytokines in Radiobiological Responses: A Review
- (2012) Dörthe Schaue et al. RADIATION RESEARCH
- Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2--Tumor and Immunological Responses
- (2012) S. K. Seung et al. Science Translational Medicine
- The role of classical and non-classical HLA class I antigens in human tumors
- (2012) Juergen Bukur et al. SEMINARS IN CANCER BIOLOGY
- Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8+T-cell immunity
- (2012) Matthew D. Brown et al. OncoImmunology
- Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy
- (2012) Jacques Thibodeau et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Clinical opportunities in combining immunotherapy with radiation therapy
- (2012) Steven E. Finkelstein et al. Frontiers in Oncology
- Effects of ionizing radiation on the immune system with special emphasis on the interaction of dendritic and T cells
- (2012) Katrin Manda et al. Frontiers in Oncology
- Radiation-induced effects and the immune system in cancer
- (2012) Punit Kaur et al. Frontiers in Oncology
- Vaccination therapy for non-small-cell lung cancer: review of agents in phase III development
- (2011) L. Decoster et al. ANNALS OF ONCOLOGY
- A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
- (2011) C. Manegold et al. ANNALS OF ONCOLOGY
- Lung Cancer Vaccines
- (2011) Ronan J. Kelly et al. CANCER JOURNAL
- Toll-like receptors
- (2011) Eva Marie Y. Moresco et al. CURRENT BIOLOGY
- Combination of External Beam Radiotherapy (EBRT) With Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients
- (2011) Steven E. Finkelstein et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
- (2011) Cheryl Lai-Lai Chiang et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Safety of BLP25 Liposome Vaccine (L-BLP25) in Japanese Patients with Unresectable Stage III NSCLC after Primary Chemoradiotherapy: Preliminary Results from a Phase I/II Study
- (2011) F. Ohyanagi et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial
- (2011) Charles Butts et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer That Progressed After Chemotherapy
- (2011) Purvish M. Parikh et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
- (2011) Vera Hirsh et al. JOURNAL OF CLINICAL ONCOLOGY
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer
- (2011) Raghunadharao Digumarti et al. Journal of Thoracic Oncology
- Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial
- (2011) Elisabeth Quoix et al. LANCET ONCOLOGY
- Contribution of the immune system to the chemotherapeutic response
- (2011) Alison M. McDonnell et al. Seminars in Immunopathology
- A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
- (2010) W J Lesterhuis et al. BRITISH JOURNAL OF CANCER
- Gene Signature in Melanoma Associated With Clinical Activity
- (2010) Thomas F. Gajewski et al. CANCER JOURNAL
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
- (2010) L. Zitvogel et al. CLINICAL CANCER RESEARCH
- A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer
- (2010) Rodryg Ramlau et al. Journal of Thoracic Oncology
- Vaccines based on abnormal self-antigens as tumor-associated antigens: Immune regulation
- (2010) Adam M. Farkas et al. SEMINARS IN IMMUNOLOGY
- Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies
- (2010) Paolo A. Ascierto et al. SEMINARS IN ONCOLOGY
- Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients
- (2009) J Nemunaitis et al. CANCER GENE THERAPY
- Cancer/testis (CT) antigens: Potential targets for immunotherapy
- (2009) Otavia L. Caballero et al. CANCER SCIENCE
- Identification of genes associated with non-small-cell lung cancer promotion and progression
- (2009) Jasna Bankovic et al. LUNG CANCER
- Immunogenic anti-cancer chemotherapy as an emerging concept
- (2008) Nicole M Haynes et al. CURRENT OPINION IN IMMUNOLOGY
- Phase II Randomized Controlled Trial of an Epidermal Growth Factor Vaccine in Advanced Non–Small-Cell Lung Cancer
- (2008) Elia Neninger Vinageras et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Christian Manegold et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started